CT SB00545

Insurance Commissioner shall conduct a study on processes used by insurance companies, hospital service corporations, medical service corporations, health care centers, and other entities to assess requests by treating health care providers to override step therapy drug regimens for patients diagnosed with metastatic cancer

Study shall examine the response time that these entities take when responding to step therapy override requests from health care providers

Report shall cover step therapy assessment procedures employed by all entities that use step therapy for prescription drugs in the state